PATOU GARY sold XENE

June 5, 2026 · Form 4 insider transaction

PATOU GARY sold 1,322 shares of Xenon Pharmaceuticals Inc. at $53.14 per share, a transaction worth $70.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Disposed (sell-side)
Shares
1,322
Price
$53.14
Total value
$70.3K
InsiderPATOU GARY
RoleDirector
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateJune 5, 2026
Filing dateJune 8, 2026
Shares owned after24,896
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 17, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025.

View the original Form 4 on SEC EDGAR